Clinical Trials Directory

Trials / Completed

CompletedNCT05688748

Effectiveness Evaluation of a Dengue Self-monitoring System

Effectiveness Evaluation of a Dengue Self-monitoring System (DeSMoS) to Reduce Treatment Delay in Malaysia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
University of Malaya · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare the effectiveness of a dengue self-monitoring system with standard care in reducing treatment delay among dengue patients receiving outpatient care. The main question it aims to answer are: • Is a dengue self-monitoring system effective in reducing treatment delay in dengue patients? Participants will use the dengue monitoring system in addition to the standard care they are receiving for outpatient follow up for dengue. Researchers will compare them with dengue patients receiving the usual standard care to see if the dengue monitoring system reduces delay in treatment seeking in patients.

Detailed description

Dengue Self-Monitoring System (DeSMoS) was developed to guide patients about warning signs and advise them to visit a doctor appropriately before their scheduled follow up on the next day, apart from motivating them to comply to the daily follow up visits at the clinic. DeSMoS is hypothesised to effectively reduce delay in treatment seeking in dengue patients. The main aim of this system is to get dengue patients to key-in their symptoms regularly via the app when they are at home. Reminders will appear on the phone to remind them to key in the symptoms thrice daily. The system is designed as a supportive tool for outpatient dengue management. It is not meant to replace to usual standard care for dengue care.

Conditions

Interventions

TypeNameDescription
OTHERDengue self-monitoring systemThe system has a symptom monitoring algorithm whereby patient would be asked to report their symptoms thrice daily (9am, 2pm and 8pm). The algorithm is developed by the researchers which consist of primary care doctors, emergency physician and infectious disease specialists. If the patient reports warning symptoms (persistent vomiting, persistent diarrhoea, abdominal pain, bleeding, difficulty breathing, feel like fainting, difficulty carrying out usual activities, drowsiness, reduced urine output and reduced urine output), the system will advise patients to seek earlier medical care instead of waiting for the scheduled appointment the next day/other days.

Timeline

Start date
2023-01-20
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2023-01-18
Last updated
2023-12-08

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT05688748. Inclusion in this directory is not an endorsement.